Literature DB >> 27677650

Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Olga A Lyubashina1,2, Sergey S Panteleev3,4, Alexey Y Sokolov3,4.   

Abstract

Electrical stimulation of the greater occipital nerve (GON) has recently shown promise as an effective non-pharmacological prophylactic therapy for drug-resistant chronic primary headaches, but the neurobiological mechanisms underlying its anticephalgic action are not elucidated. Considering that the spinal trigeminal nucleus (STN) is a key segmental structure playing a prominent role in pathophysiology of headaches, in the present study we evaluated the effects of GON electrical stimulation on ongoing and evoked firing of the dura-sensitive STN neurons. The experiments were carried out on urethane/chloralose-anesthetized, paralyzed and artificially ventilated male Wistar rats. Extracellular recordings were made from 11 neurons within the caudal part of the STN that received convergent input from the ipsilateral facial cutaneous receptive fields, dura mater and GON. In each experiment, five various combinations of the GON stimulation frequency (50, 75, 100 Hz) and intensity (1, 3, 6 V) were tested successively in 10 min interval. At all parameter sets, preconditioning GON stimulation (250 ms train of pulses applied before each recording) produced suppression of both the ongoing activity of the STN neurons and their responses to electrical stimulation of the dura mater. The inhibitory effect depended mostly on the GON stimulation intensity, being maximally pronounced when a stimulus of 6 V was applied. Thus, the GON stimulation-induced inhibition of trigeminovascular nociceptive processing at the level of STN has been demonstrated for the first time. The data obtained can contribute to a deeper understanding of neurophysiological mechanisms underlying the therapeutic efficacy of GON stimulation in primary headaches.

Entities:  

Keywords:  Dural electrical stimulation; Greater occipital nerve stimulation; Headache; Neuronal activity; Trigeminal nerve; Trigeminovascular system

Mesh:

Year:  2016        PMID: 27677650     DOI: 10.1007/s00702-016-1626-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  101 in total

1.  [Effect of GABA-positive drugs on the background and superior sagittalis sinus-electrostimulated activity of neurons in the nucleus trigeminalis caudalis of rats].

Authors:  A Iu Sokolov; A V Amelin; Iu D Ignatov; S S Panteleev
Journal:  Eksp Klin Farmakol       Date:  2008 Sep-Oct

Review 2.  Neurostimulation for primary headache disorders: Part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation.

Authors:  Brian Jenkins; Stewart J Tepper
Journal:  Headache       Date:  2011-08-03       Impact factor: 5.887

3.  Occipital nerve stimulation in the treatment of medically intractable SUNCT and SUNA.

Authors:  Giorgio Lambru; Paul Shanahan; Laurence Watkins; Manjit Singh Matharu
Journal:  Pain Physician       Date:  2014 Jan-Feb       Impact factor: 4.965

4.  Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  J Pharmacol Exp Ther       Date:  2006-10-03       Impact factor: 4.030

5.  Occipital nerve stimulation for refractory headache in the Chiari malformation population.

Authors:  Sudhakar Vadivelu; Paolo Bolognese; Thomas H Milhorat; Alon Y Mogilner
Journal:  Neurosurgery       Date:  2012-06       Impact factor: 4.654

Review 6.  Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.

Authors:  Simon Akerman; Philip R Holland; Jan Hoffmann
Journal:  Cephalalgia       Date:  2013-06       Impact factor: 6.292

7.  Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input.

Authors:  Thorsten Bartsch; Peter J Goadsby
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

8.  Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study.

Authors:  Brian Burns; Laurence Watkins; Peter J Goadsby
Journal:  Lancet Neurol       Date:  2008-10-07       Impact factor: 44.182

9.  Peripheral neurostimulation in the management of cervicogenic headache: four case reports.

Authors:  Maria Dolores Rodrigo-Royo; Jose Miguel Azcona; Jose Quero; Maria Cristina Lorente; Pilar Acín; Javier Azcona
Journal:  Neuromodulation       Date:  2005-10

10.  Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.

Authors:  Carrie E Robertson; Ivan Garza
Journal:  Neuropsychiatr Dis Treat       Date:  2012-01-13       Impact factor: 2.570

View more
  2 in total

Review 1.  Mechanism of Peripheral Nerve Stimulation in Chronic Pain.

Authors:  Tiffany Lin; Akshat Gargya; Harmandeep Singh; Eellan Sivanesan; Amitabh Gulati
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

Review 2.  Peripheral Neuromodulation for the Management of Headache.

Authors:  Ivan Urits; Ruben Schwartz; Daniel Smoots; Lindsey Koop; Suhitha Veeravelli; Vwaire Orhurhu; Elyse M Cornett; Laxmaiah Manchikanti; Alan D Kaye; Farnad Imani; Giustino Varrassi; Omar Viswanath
Journal:  Anesth Pain Med       Date:  2020-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.